Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$382M |
| 2 |
Pfizer
PFE
|
+$266M |
| 3 |
EA
Electronic Arts
EA
|
+$240M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Colgate-Palmolive
CL
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$358M |
| 2 |
Comcast
CMCSA
|
+$263M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
AET
Aetna Inc
AET
|
+$257M |
| 5 |
Tesla
TSLA
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.13% |
| 2 | Technology | 13.55% |
| 3 | Financials | 11.85% |
| 4 | Consumer Staples | 10.18% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Moog Inc Class A
MOG.A
$13.3B
| – | – |
-10,600
| Closed | -$714K |
|
3302
Everspin Technologies
MRAM
$423M
| – | – |
-15,000
| Closed | -$126K |
|
|
MRC
3303
DELISTED
MRC Global
MRC
| – | – |
-566,700
| Closed | -$10.4M |
|
3304
Mercury Systems
MRCY
$6.56B
| – | – |
-89,167
| Closed | -$3.48M |
|
|
MRUS
3305
DELISTED
Merus
MRUS
| – | – |
-22,500
| Closed | -$549K |
|
3306
ArcelorMittal
MT
$56.1B
| – | – |
-1,586,918
| Closed | -$39.8M |
|
|
MVO
3307
DELISTED
MV Oil Trust
MVO
| – | – |
-14,850
| Closed | -$91K |
|
3308
Mexco Energy
MXC
$20.5M
| – | – |
-10,900
| Closed | -$42K |
|
3309
Myriad Genetics
MYGN
$299M
| – | – |
-534,700
| Closed | -$10.3M |
|
3310
Navient
NAVI
$793M
| – | – |
-346,300
| Closed | -$5.11M |
|
|
SDEV
3311
Stablecoin Development Corp
SDEV
$51.5M
| – | – |
-2
| Closed | -$42K |
|
3312
Newmont
NEM
$126B
| – | – |
-630,540
| Closed | -$20.8M |
|
3313
NeoGenomics
NEO
$2.11B
| – | – |
-308,664
| Closed | -$2.44M |
|
3314
Navios Maritime Partners
NMM
$2.24B
| – | – |
-51,787
| Closed | -$1.61M |
|
3315
Nu Skin
NUS
$248M
| – | – |
-48,300
| Closed | -$2.68M |
|
|
NVEE
3316
DELISTED
NV5 Global
NVEE
| – | – |
-56,400
| Closed | -$530K |
|
3317
Ocular Therapeutix
OCUL
$2.22B
| – | – |
-88,900
| Closed | -$825K |
|
|
ODP
3318
DELISTED
ODP
ODP
| – | – |
-209,383
| Closed | -$9.77M |
|
3319
O-I Glass
OI
$1.06B
| – | – |
-195,753
| Closed | -$3.99M |
|
3320
VanEck Oil Services ETF
OIH
$1.97B
| – | – |
-4,305
| Closed | -$2.65M |
|
3321
Olin
OLN
$2.13B
| – | – |
-24,500
| Closed | -$805K |
|
3322
Oshkosh
OSK
$9.46B
| – | – |
-163,800
| Closed | -$11.2M |
|
3323
Oxbridge Re Holdings
OXBR
$10.2M
| – | – |
-11,400
| Closed | -$75K |
|
3324
Pampa Energía
PAM
$4.28B
| – | – |
-10,800
| Closed | -$586K |
|
3325
Par Pacific Holdings
PARR
$3.75B
| – | – |
-313,700
| Closed | -$5.17M |
|
Similar funds
Jim Simons's Q2 2017 Portfolio in Review
As of Q2 2017, Jim Simons held 3,586 positions worth $78.4B, up 9.5% from $71.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Jim Simons deployed $4.59B of net new capital in Q2 2017, opening 398 new positions and adding to 1,648 existing holdings. Its largest new stake was Pfizer: 8,421,609 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Comcast, an estimated $263M trimmed.
- Jim Simons's largest Q2 2017 buy was Pfizer: 8,421,609 shares worth $268M.
- Jim Simons added most to Bristol-Myers Squibb in Q2 2017, an estimated $382M increase.
- Jim Simons's biggest Q2 2017 reduction was Comcast, cutting an estimated $263M.
- Jim Simons fully exited Booking.com in Q2 2017, selling an estimated $358M.
- Jim Simons's ten largest holdings make up 9% of its $78.4B portfolio in Q2 2017.
- Jim Simons opened 398 new positions and closed 418 in Q2 2017.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $78.4B.
Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.